114 Items
ID | ncRNA_Name | Disease_Name | Application | PMID | Detail |
---|---|---|---|---|---|
MID_109 | A combination of hsa-miR-29b-3p and IL-6 | Atherosclerosis | Diagnosis | 29197872 | |
MID_110 | hsa-let-7c | Atherosclerosis | Treatment | 22917031 | |
MID_111 | hsa-let-7g-5p | Atherosclerosis | Treatment | 28535009 | |
MID_112 | hsa-miR-10b-5p | Atherosclerosis | Treatment | 22370758 | |
MID_113 | hsa-miR-100-5p | Atherosclerosis | Diagnosis | 26159918 | |
MID_114 | hsa-miR-105-5p | Atherosclerosis | Treatment | 22370758 | |
MID_115 | hsa-miR-106b-5p | Atherosclerosis | Treatment | 27270534 | |
MID_116 | hsa-miR-122-5p | Atherosclerosis | Diagnosis | 24848278 | |
MID_117 | hsa-miR-125a-5p | Atherosclerosis | Treatment | 22370758 | |
MID_118 | hsa-miR-125a-5p | Atherosclerosis | Diagnosis | 24517143 | |
MID_119 | hsa-miR-126-3p | Atherosclerosis | Treatment | 27870587 | |
MID_120 | hsa-miR-126-3p | Pre-atherosclerotic(patients with hyperlipidemia, hypertension, and or/diabetes) | Diagnosis | 24848278 | |
MID_121 | hsa-miR-126-3p | Atherosclerosis | Diagnosis | 24848278 | |
MID_122 | hsa-miR-126-3p | Atherosclerosis | Diagnosis | 24517143 | |
MID_123 | hsa-miR-126-3p | Atherosclerosis | Treatment | 29203244 | |
MID_124 | hsa-miR-1273a | Atherosclerosis | Diagnosis | 26159918 | |
MID_125 | hsa-miR-130a-3p | Pre-atherosclerotic(patients with hyperlipidemia, hypertension, and or/diabetes) | Diagnosis | 24848278 | |
MID_126 | hsa-miR-130a-3p | Atherosclerosis | Diagnosis | 24848278 | |
MID_127 | hsa-miR-130a-3p | Arteriosclerosis obliterans | Diagnosis | 20888330 | |
MID_128 | hsa-miR-135b-5p | Atherosclerosis | Treatment | 26184978 | |
MID_129 | hsa-miR-136-5p | Atherosclerosis | Treatment | 25409743 | |
MID_130 | hsa-miR-142-3p | Atherosclerosis | Treatment | 29949787 | |
MID_131 | hsa-miR-143-3p | Atherosclerosis | Diagnosis | 27775792 | |
MID_132 | hsa-miR-143-MM2 | Atherosclerosis | Treatment | 22370758 | |
MID_133 | hsa-miR-145-5p | Atherosclerosis | Treatment | 26992033 | |
MID_134 | hsa-miR-145-5p | Atherosclerosis | Treatment | 29710501 | |
MID_135 | hsa-miR-146a-5p | Atherosclerosis | Diagnosis | 21820659 | |
MID_136 | hsa-miR-146a-5p SNP rs2910164 | Atherosclerotic cerebral infarction(ACI) | Diagnosis, Treatment | 26875519 | |
MID_137 | hsa-miR-146a-5p SNP rs2910164 | Type 2 diabetes mellitus with carotid vulnerable plaque risk | Diagnosis | 26505665 | |
MID_138 | hsa-miR-146b-5p | Atherosclerosis | Diagnosis | 21820659 | |
MID_139 | hsa-miR-147a | Atherosclerosis | Treatment | 22370758 | |
MID_140 | hsa-miR-150-5p | Atherosclerosis | Treatment | 28254813 | |
MID_141 | hsa-miR-152 | Atherosclerosis | Treatment | 22370758 | |
MID_142 | hsa-miR-155-5p | Atherosclerosis | Treatment | 26899994 | |
MID_143 | hsa-miR-155-5p | Atherosclerosis | Diagnosis | 26159918 | |
MID_144 | hsa-miR-15b-5p | Atherosclerosis | Treatment | 22370758 | |
MID_145 | hsa-miR-17-3p | Atherosclerosis | Treatment | 22370758 | |
MID_146 | hsa-miR-17-5p | Coronary atherosclerosis | Diagnosis | 26134369 | |
MID_147 | hsa-miR-181a-5p | Atherosclerosis | Treatment | 27460740 | |
MID_148 | hsa-miR-181a-5p | Atherosclerosis | Treatment | 22370758 | |
MID_149 | hsa-miR-181b-5p | Atherosclerosis | Treatment | 26420120 | |
MID_150 | hsa-miR-181b-5p | Atherosclerosis | Treatment | 29136944 | |
MID_151 | hsa-miR-181b-5p | Atherosclerosis | Treatment | 27756793 | |
MID_152 | hsa-miR-185-5p | Atherosclerosis | Treatment | 22370758 | |
MID_153 | hsa-miR-186-5p | Atherosclerosis | Treatment | 22370758 | |
MID_154 | hsa-miR-19a-3p | Atherosclerosis | Treatment | 27497158 | |
MID_155 | hsa-miR-210 | Atherosclerosis | Treatment | 27895035 | |
MID_156 | hsa-miR-210 | Atherosclerosis | Diagnosis | 21820659 | |
MID_157 | hsa-miR-210 | Arteriosclerosis obliterans | Diagnosis | 20888330 | |
MID_158 | hsa-miR-211-5p | Atherosclerosis | Diagnosis | 26159918 | |
MID_159 | hsa-miR-211-5p | Atherosclerosis | Diagnosis | 24848278 | |
MID_160 | hsa-miR-212-3p | Atherosclerosis | Diagnosis | 28557988 | |
MID_161 | hsa-miR-21-5p | Atherosclerosis | Diagnosis | 24848278 | |
MID_162 | hsa-miR-21-5p | Atherosclerosis | Diagnosis | 21820659 | |
MID_163 | hsa-miR-21-5p rs145204276 | Atherosclerosis | Treatment | 30205366 | |
MID_164 | hsa-miR-21-5p, hsa-miR-126-3p with NT-pro-BNP 0r cTN-I | Atherosclerosis | Diagnosis | 24848278 | |
MID_165 | hsa-miR-217 | Atherosclerosis with hyperhomocysteinemia | Diagnosis, Prognosis | 29461880 | |
MID_166 | hsa-miR-218-5p | Atherosclerosis | Treatment | 22370758 | |
MID_167 | hsa-miR-220 | Atherosclerosis | Treatment | 22370758 | |
MID_168 | hsa-miR-221-3p | Atherosclerosis | Diagnosis | 24517143 | |
MID_169 | hsa-miR-221-3p | Atherosclerosis | Prognosis | 26451018 | |
MID_170 | hsa-miR-221-3p | Atherosclerosis | Diagnosis | 29695561 | |
MID_171 | hsa-miR-222-3p | Atherosclerosis | Prognosis | 26451018 | |
MID_172 | hsa-miR-222-3p | Pre-atherosclerotic(patients with hyperlipidemia, hypertension, and or/diabetes) | Diagnosis | 24848278 | |
MID_173 | hsa-miR-222-3p | Atherosclerosis | Diagnosis | 24848278 | |
MID_174 | hsa-miR-222-3p | Atherosclerosis | Diagnosis | 24517143 | |
MID_175 | hsa-miR-222-3p | Atherosclerosis | Diagnosis | 29695561 | |
MID_176 | hsa-miR-223-3p | Atherosclerotic cerebral infarction | Diagnosis, Treatment | 28683362 | |
MID_177 | hsa-miR-24-3p | Atherosclerosis | Treatment | 29250154 | |
MID_178 | hsa-miR-26a-5p | Atherosclerosis | Treatment | 25801675 | |
MID_179 | hsa-miR-26b-5p | Atherosclerosis | Treatment | 22370758 | |
MID_180 | hsa-miR-27b-3p | Arteriosclerosis obliterans | Diagnosis | 20888330 | |
MID_181 | hsa-miR-29a-3p | Atherosclerosis | Diagnosis | 28250354 | |
MID_182 | hsa-miR-29b-3p | Atherosclerosis | Diagnosis | 29197872 | |
MID_183 | hsa-miR-29c-3p | Atherosclerosis | Diagnosis | 30308507 | |
MID_184 | hsa-miR-30 | Atherosclerosis | Diagnosis | 27379414 | |
MID_185 | hsa-miR-30c-5p | Atherosclerosis | Diagnosis, Treatment | 29016810 | |
MID_186 | hsa-miR-30e-5p | Atherosclerosis | Treatment | 22370758 | |
MID_187 | hsa-miR-3188 | Atherosclerosis | Diagnosis, Treatment | 29442044 | |
MID_188 | hsa-miR-320b | Carotid atherosclerosis | Diagnosis | 27460454 | |
MID_189 | hsa-miR-33a-5p | Atherosclerosis | Diagnosis | 27664032 | |
MID_190 | hsa-miR-33b-5p | Atherosclerosis | Treatment | 25445880 | |
MID_191 | hsa-miR-34a-5p | Atherosclerosis | Diagnosis | 21820659 | |
MID_192 | hsa-miR-34a-5p | Atherosclerosis | Treatment | 29328474 | |
MID_193 | hsa-miR-362-3p | Atherosclerosis | Diagnosis, Treatment | 28890348 | |
MID_194 | hsa-miR-365a-3p | Coronary atherosclerosis | Diagnosis | 28051250 | |
MID_195 | hsa-miR-370 | Pre-atherosclerotic(patients with hyperlipidemia, hypertension, and or/diabetes) | Diagnosis | 24848278 | |
MID_196 | hsa-miR-378a-3p | Atherosclerosis | Treatment | 22370758 | |
MID_197 | hsa-miR-422a | Atherosclerosis | Treatment | 22370758 | |
MID_198 | hsa-miR-489 | Atherosclerosis | Treatment | 22370758 | |
MID_199 | hsa-miR-491-5p SNP rs1056629 | Atherosclerotic cerebral infarction | Diagnosis | 23257658 | |
MID_200 | hsa-miR-494 | Atherosclerosis | Treatment | 26583674 | |
MID_201 | hsa-miR-499a-3p | Atherosclerosis | Treatment | 26184978 | |
MID_202 | hsa-miR-520b | Atherosclerosis | Treatment | 22370758 | |
MID_203 | hsa-miR-524-5p | Atherosclerosis | Treatment | 22370758 | |
MID_204 | hsa-miR-664a-3p | Atherosclerosis | Diagnosis | 29419680 | |
MID_205 | hsa-miR-758-3p | Atherosclerosis | Treatment | 25445880 | |
MID_206 | hsa-miR-92a-3p | Pre-atherosclerotic(patients with hyperlipidemia, hypertension, and/or diabetes) | Diagnosis | 24848278 | |
MID_207 | hsa-miR-92a-3p | Atherosclerosis | Diagnosis | 24848278 | |
MID_208 | hsa-miR-92a-3p | Atherosclerosis | Diagnosis | 27629245 | |
MID_209 | hsa-miR-98-5p | Atherosclerosis | Treatment | 22370758 | |
MID_210 | N1 | Atherosclerosis | Diagnosis | 25728006 | |
MID_211 | N3 | Atherosclerosis | Diagnosis | 25728006 | |
MID_212 | pre-miR-146a rs2910164 | Atherosclerosis | Diagnosis | 28674224 | |
MID_213 | pre-miR-499 rs3746444 | Atherosclerosis | Diagnosis | 28674224 | |
LID_3 | ANRIL(Cyclin-dependent kinase inhibitor 2B antisense RNA 1) | Atherosclerosis | Diagnosis | 29035780 | |
LID_4 | lnc-KDM5D-4 | Atherosclerosis | Treatment | 29196750 | |
LID_5 | MALAT1(Metastasis-associated lung adenocarcinoma transcript 1) | Atherosclerosis | Diagnosis | 29035780 | |
LID_6 | MIAT(Myocardial infarction-associated transcript) | Atherosclerosis | Diagnosis | 29035780 | |
LID_7 | MIAT(Myocardial infarction-associated transcript) | Atherosclerosis | Treatment | 29136944 | |
LID_8 | RNCR3 | Atherosclerosis | Treatment | 27253412 | |
CID_1 | cANRIL(circular ANRIL) | Atherosclerotic vascular disease | Diagnosis | 21151960 | |
CID_2 | cANRIL(circular antisense non-coding RNA in the INK4 locus) | Atherosclerosis | Treatment | 27539542 | |
CID_3 | Ratio of circR-284/miR-221 | Atherosclerosis | Diagnosis | 28779016 |